The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
And a long list of industry partnerships such as:
1 February 2021
Avacta’s next generation cell and gene therapy joint venture with Daewoong Pharmaceutical secures Series A venture funding
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that AffyXell Therapeutics ("AffyXell"), the joint venture with Daewoong Pharmaceutical ("Daewoong"), has closed a Series A venture capital investment of $7.3 million to further develop its pipeline of next generation cell and gene therapies.
https://twitter.com/Ophidian18/status/1439848125426974722
Ophidian
@Ophidian18
A month on and 2 additional (different sources) confirmations over the weekend means I'm still expecting news by month end just as I outlined before. #AVCT.
Quote Tweet
Ophidian
@Ophidian18
· Aug 20
It has been reported to me that Medusa19 staff have confirmed in conversations that Medusa will be making AffiDX at their facilities, before the end of September, for sale to consumers for Home Use. #AVCT
Show this thread
Probably already regrets the tweet
-----------------------------------------------
Nacapital
@NAJJCAPITAL
·
21m
Replying to
@AvactaDx
What is the status of tt with Abdx?
What is the status of tt with non disclosed EU manufacturers?
2
D J C
@DJBULL85_
·
8m
Replying to
@AvactaDx
‘A reminder that you have shareholders and the importance of delivering on the ‘STRONG DEMAND’ you spoke about constantly! Where are the promised orders?
DH2
@DH251880851
·
23m
Replying to
@AvactaDx
Where is your "Home use authorisation" please?
3
James Kirrane
@JESKirrane
·
16m
Replying to
@AvactaDx
Any news on HUA? TT to Abingdon? 20 European distributors? European manufacturer? Asian manufacturer? Medusa19 partnership? Just any news at all?
1
Neil
@nellyboy666
·
11m
A little update, anything before the results preso at the end of the month would be most welcome. Can’t be too much to ask can it!?
https://mobile.twitter.com/AvactaDx/status/1438054416016359425
And on top of what Losta says I'll add that Dr Mark Goldberg and the new Science Advisory Board would not have joined up to fail....not even remotely. They know it works and my betting is they'll all have ex-colleagues working in Royal Marsden. It's a small world at that level.
@MylesMcNulty
...share price catalyst in the near term is Home Use Authorization for #AVCT's AffiDX #COVID19 LFT.
This is how the mega sales volumes will be generated.
@AvactaDx
's job is now (largely) done on that front. It's now down to
@medusa19_
to deliver.
If / when HUA lands... 10/12
Myles McNulty
@MylesMcNulty
...the marketing push will begin in earnest. I imagine
@medusa19_
will have numerous sub-distributors lined up already, and advertising / marketing strategies in place.
Can the
@boohoo
founders build another mega direct-to-consumer success, with
@medusa19_
?
IF it can... 11/12
Myles McNulty
@MylesMcNulty
·
..., #AVCT could have a superb distribution partner for
@AvactaDx
's next AffiDX products in the years ahead.
Back to the 'Punt': my belief is that
@AvactaDx
alone now covers #AVCT's 120p valuation.
Which makes the current 'odds' for AVA6k, even more ridiculously priced.
12/12
Myles McNulty
@MylesMcNulty
·
1h
Purely from a short term (<3 month) 'Punt' perspective, #AVCT's valuation is wrong. The odds do not stack up. The (majority of the) UK market does not get the story.
That is why I am quite sure AVCT is planning a NASDAQ listing.
https://twitter.com/MylesMcNulty/status/1437772713548992519....a longish read
SureScreen get a mention!! Their street traders web site doesn't work ...... try the antigen link....better luck than me if it works.
It fits Bethell like a glove.
https://www.surescreen.com/products/covid-19-coronavirus-antigen